TRPM5 mediates acidic extracellular pH signaling and TRPM5 inhibition reduces spontaneous metastasis in mouse B16-BL6 melanoma cells

Toyonobu Maeda,Atsuko Suzuki,Kaori Koga,Chihiro Miyamoto,Yojiro Maehata,Shigeyuki Ozawa,Ryu-Ichiro Hata,Yoji Nagashima,Kazuki Nabeshima,Kaoru Miyazaki,Yasumasa Kato
DOI: https://doi.org/10.18632/oncotarget.20826
2017-09-11
Oncotarget
Abstract:Extracellular acidity is a hallmark of solid tumors and is associated with metastasis in the tumor microenvironment. Acidic extracellular pH (pH <sub><i>e</i></sub> ) has been found to increase intracellular Ca<sup>2+</sup> and matrix metalloproteinase-9 (MMP-9) expression by activating NF-κB in the mouse B16 melanoma model. The present study assessed whether TRPM5, an intracellular Ca<sup>2+</sup>-dependent monovalent cation channel, is associated with acidic pH <sub><i>e</i></sub> signaling and induction of MMP-9 expression in this mouse melanoma model. Treatment of B16 cells with <i>Trpm5</i> siRNA reduced acidic pH <sub><i>e</i></sub> -induced MMP-9 expression. Enforced expression of <i>Trpm5</i> increased the rate of acidic pH <sub><i>e</i></sub> -induced MMP-9 expression, as well as increasing experimental lung metastasis. This genetic manipulation did not alter the pH <sub><i>e</i></sub> critical for MMP-9 induction but simply amplified the percentage of inducible MMP-9 at each pH <sub><i>e</i></sub> . Treatment of tumor bearing mice with triphenylphosphine oxide (TPPO), an inhibitor of TRPM5, significantly reduced spontaneous lung metastasis. <i>In silico</i> analysis of clinical samples showed that high <i>TRPM5</i> mRNA expression correlated with poor overall survival rate in patients with melanoma and gastric cancer but not in patients with cancers of the ovary, lung, breast, and rectum. These results showed that TRPM5 amplifies acidic pH <sub><i>e</i></sub> signaling and may be a promising target for preventing metastasis of some types of tumor.
What problem does this paper attempt to address?